# Lonza completes acquisition of Capsugel for USD 5.5 billion

Lonza completed the acquisition of Capsugel from KKR for USD 5.5 billion in cash, including refinancing of approximately USD 2 billion in existing Capsugel debt.

- Type: Acquisition
- Announced: 2017-07-06
- Where: Switzerland
- Value: $5.50B
- Status: completed
- Products: capsules, pharmaceutical development and manufacturing services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [KKR](https://endata.com/companies/16879.md) (investor)
- [Lonza Group AG](https://endata.com/companies/20735.md) (acquirer)
- [Capsugel S.A.](https://endata.com/companies/20736.md) (target)

## Sources

- [bionity.com](https://www.bionity.com/en/news/164011/lonza-completes-acquisition-of-capsugel.html), 2017-07-06: "Lonza and Capsugel have a highly synergistic customer base and market approach, complementary business models and closely aligned corporate cultures."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.